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Abstract 
AIM: The purpose of this study was to determine the level of significance of markers in the development of intra-
abdominal hypertension in patients with acute surgical diseases of the abdominal cavity. 
METHODS: The authors surveyed 100 patients who were monitored at the Regional Clinical Hospital, Karaganda. 
The criterion for inclusion in the study was the informed consent of patients to participate in the study, the 
presence of acute surgical pathology, and the monitoring of intra-abdominal pressure over time. The exclusion 
criteria for patients from the study is the presence of sub and decompensation of associated diseases: trauma 
(hematoma of the bladder), bladder tumour and impaired integrity of the pelvic ring. The design of the study was 
by the legislation of the Republic of Kazakhstan, international ethical norms and normative documents of research 
organizations, approved by the ethics committee of the Karaganda State Medical University. 
RESULTS: According to the world scientific literature, there are 4 indicators that change their value in response to 
increases in pressure in the abdominal cavity: fibrinogen and prothrombin index (the main indicators of the 
coagulogram); marker of blood clots D-dimer; early marker of translocation of bacterial flora into the bloodstream 
sCD14 (presepsin). 
CONCLUSION: The authors concluded that the obtained data indicate that an increase in intra-abdominal 
pressure in acute surgical diseases of the abdominal cavity causes hypercoagulation and an increase in 
presepsin. Monitoring IAP with simultaneous measurement of the level of presepsin significantly improves the 
stratification of critical patients in need of emergency surgery. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Intraabdominal hypertension (IAH, 
intraabdominal pressure, IAP) is one of the most 
dangerous complications of the abdominal 
catastrophe in patients with acute surgical diseases. 
The main reason for the lethality from abdominal 
compartment syndrome is the translocation of 
microorganisms with the development of abdominal 
sepsis. Surgical abdominal sepsis takes 30% from all 
it cases [1] and is the principal cause of the death rate 
in the surgical departments of intensive therapy (IT) 
[2], [3]. The multivariable character of development of 
acute surgical pathology of abdominal organs, a 
complication of pathogenesis, creates problems for 
determination of diagnostics criteria and an adequate 
surgical correction. The traditional biomarkers of 
systemic inflammatory response syndrome (SIRS) or 
abdominal sepsis are not always sufficiently 
informative for early diagnosis and monitoring of 
systemic infection. 
Currently focuses on the study of presepsin 
and D-Dimer for an in-depth understanding of SIRS, 
abdominal sepsis and severe sepsis. 
Presepsin is the circulating concentration of 
protein in the blood increases rapidly with the 
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development of systemic infections, sepsis, severe 
sepsis and septic shock, it was first described in 2005 
by a group of researchers from the Medical University, 
Iwate, Japan [4]. 
Presepsin is a membrane glycoprotein with a 
molecular weight of 55 kDa. The mCD14 is expressed 
on the surface of monocytes/macrophages, 
neutrophils, chondrocytes, the cells, dendritic cells 
and other mature myeloid cells [5], [6]. 
The mCD14 is a receptor, which "learns" the 
signal of the infecting bacteria presence and turns the 
nonspecific immunity system and inflammatory 
process on [7], [8].  
The mCD14 may independently communicate 
with LPS and turns activation signal of macrophages, 
a special lipopolysaccharide-binding protein on (LSB, 
LBP lipopolysaccharide-binding protein), improves the 
effectiveness of such a binding in the 100-1000 times. 
In vivo, at low LPS (low numbers of bacteria 
that can grow quickly) LSB in advance "strengthens" 
signal for activation of the inflammatory response [9]. 
In addition to endotoxin of gram-negative 
bacteria, LSB specifically binds to cell wall 
components: gram-positive bacteria — lipoteichoic 
acids, peptidoglycans [10]; mycobacteria — 
lipoproteins, lipomannans [11]; Mycoplasma — 
lipopeptides [12]; spirochete — glycolipids and 
lipoproteins [13] and fungi [14]. The spectrum of 
microorganisms, activating monocytes/macrophages 
through interaction with mCD14 are very wide. The 
mCD14 receptor associated with the LSB-LPS 
complex is activated and transmits a signal to the 
TLR4 co-receptor located next to the membrane and 
related to the so-called Toll-like receptors (Toll-like 
receptor), which activate non-specific immunity. After 
activation of macrophages mCD14 is disconnected 
from the membrane, goes into circulation and 
becomes soluble sCD14 (s-soluble). sCD14 function-
is induction of inflammation in endothelial and other 
cells that do not have mCD14 and do not respond to 
endotoxins. It is assumed that the circulating sCD14-
marker of monocyte response to the action of LPS; 
increased blood sCD14 levels are associated with the 
severity of inflammation and septic shock [15]. 
Presepsin is an early biomarker of sepsis 
development, which reliability is 100%, confirmed by 
hemocultures, diagnoses sepsis is defined before 
manifestation of clinical symptoms and predicts 
treatment outcomes, with dynamic monitoring, reflects 
the real severity of sepsis, changes rapidly depending 
on the effectiveness of therapy, predicts recurrence of 
sepsis after remission, when clinical characteristics 
temporarily normalize [16], [17], [18], [19], [20], [21], 
[22]. 
The purpose of the study was to assess the 
relationship of the level of presepine with the 
development of intraabdominal hypertension in 
patients with acute surgical deseases. 
Material and Methods 
 
The present study is based on clinical 
observations of 100 patients with various acute 
surgical diseases who were hospitalised and operated 
in the regional clinical hospital of Karaganda in 2017. 
Among them 52 (52%) men and 48 (48%) women. 
The number of men as a whole exceeded the number 
of women by an average of 1.08 times. 
The design of this study was approved by the 
ethical Commission at Karaganda state medical 
University. 
The age of patients ranged from 20 to 80 
years (mean age — 46.66 years). At the same time, 
the age composition was dominated by young 
patients: younger than 25 years – (7.3%), 25-44 years 
– (38.1%), 45-60 years – (29.3%), older than 60 years 
– (25.3%) patients. It was found that the prevalence of 
diseases of the abdominal cavity is high in the groups 
of patients 25-44 and 45-60 years. 
Clinical and laboratory-instrumental 
examination of patients with acute surgical pathology 
before surgery allowed to distribute patients according 
by nosology (the structure of patients):  
- acute appendicitis 16 (16%),  
- acute intestinal obstruction 37 (37%) 
patients,  
- pancreonecrosis 5 (5%),  
- perforated ulcer 22 (22%) patients,  
- acute cholecystitis (mechanical jaundice) 15 
(15%) patients,  
- varicose veins of the lower extremities 
(control group) 5 (5%) patients. 
Criteria for inclusion of patients in the study 
were the presence of acute surgical pathology: acute 
intestinal obstruction, acute appendicitis, pancreatic 
necrosis, perforated ulcer, acute cholecystitis 
(mechanical jaundice),  
Control group is the patients with varicose 
veins of the lower extremities; the age of patients 20-
80 years of age; disease duration more than 24 hours. 
Group of patients: 
1. group-patients with IAD within normal limits 
(0-4 mmHg). 
2. group-patients with IAD 5-15 mmHg art. 
3. group-patients with IAD 16-25 mmHg art. 
4. group-patients with IAD 26-35 and more 
mmHg. 
A common criterion for excluding patients 
from the study (for all groups) is the presence of sub-
and decompensation (remission) of comorbidities, 
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injury (hematoma) and swelling of the bladder. 
Concomitant pathology in the studied patients was in 
remission, which was confirmed by anamnesis and 
clinical and laboratory.  
Measurement of IAP was carried out using 
the device "Triton-electronics", invasive portable 
electronic meter Autonomous Central venous 
pressure and other low pressures in various cavities 
of the human body.  
25 or 50 ml of warm sterile isotonic sodium 
chloride solution was injected into the emptied bladder 
with a syringe without a needle. The urinary catheter 
was connected to the device "Triton-electronics". The 
zero value was set at the level of the pubic junction.  
Currently, this method is the "gold standard" 
for indirect measurement of intraabdominal pressure. 
All patients underwent 3 measurements of 
intraabdominal pressure-before surgery, as well as 6 
and 24 hours after surgery. 
As a result of the IAP measurement of all 
patients before surgery were divided into 4 groups 
depending on the degree of IPG:  
0 group-IAP 0-11 mm Hg, 6 patients (6%),  
group 1-IAP 12-15 mm Hg, 9 patients (9%),  
group 2-IAP 16-20 mm Hg, 26 patients (26%),  
group 3-IAP 21-25 mm Hg, 23 patients (23%), 
group 4-IAP more than 25 mm Hg, 36 patients 
(24%). 
 
 
 
Results 
 
According to the world scientific literature, 
there are 4 indicators that change their value in 
response to increased abdominal pressure: fibrinogen 
and prothrombin index (PTI) (the main indicators of 
coagulation); a marker of thrombosis D-dimer; an 
early marker of bacterial flora translocation into blood 
flow sCD14 (presepsin).  
Statistical processing of the results of the 
study was carried out by methods of variation 
statistics with the calculation of each indicator of the 
median and standard deviation (sd). The significance 
of differences in the groups was determined using 
nonparametric methods of statistical evaluation: peer-
to-peer analysis of variance (ANOVA). Differences 
were considered statistically significant at p < 0.05. 
Table 1 shows the median and standard 
deviation (SD) of these markers by groups. 
 
Table 1: Average and spread of markers value by groups 
IAP до Count Prothrombin 
index 
Fibrinogen sCD14 D-dimer 
Median SD Median SD Median SD Median SD 
< 12 6 90.9 30.1 3.5 0.782 246 162 5.88 13.5 
12-15 9 90.1 9.41 4.68 1.15 570 186 24.6 11.2 
16-20 26 87.9 18.1 4.65 2.22 651 384 35.3 33.2 
21-25 23 78.6 24.3 5.1 1.65 656 336 36.5 35 
> 25 36 78.7 26.4 5.94 2.82 800 572 28.2 18.1 
 
The median of the prothrombin index in the 
blood plasma decreased with an increase in intra-
abdominal pressure (IAP). Although the spread of this 
indicator in each group is quite large, it is larger than 
the difference of averages between any groups. This 
difference is not statistically significant. The figure 
below clearly shows that the values of this indicator 
are the same in all groups. 
The median of the prothrombin index in the 
control group is 90.9%, which is within the known 
norm of PTI 80-110%. 
IAP 12-20 mmHg (group 1 and 2)-normal 
values. 
IAP 21-25 and more mmHg (group 3 and 4) 
leads to decrease of PTI compared to normal values 
(there are statistically significant differences compared 
to the control group and group 1 and 2, in the direction 
of hypercoagulation, which possibly associated with a 
massive flow of tissue thromboplastin into the 
bloodstream (Figure 1).  
 
Figure 1: Dependence of the content of PTI in plasma on the level 
of IAP 
 
The values of fibrinogen, CD14 and D-dimer 
in the control group are less than in other groups. 
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Figure 2: Dependence of the content of fibrinogen in plasma on the 
level of IAP 
 
The content of fibrinogen in the blood plasma 
increases in proportion to the increase in pressure in 
the abdominal cavity. There is a statistically significant 
difference in the groups with IAH and control group (0 
groups). Thus, the average concentration of fibrinogen 
in the control group is 3.5 g/l, which is within the 
known norm of fibrinogen 2.0 – 4.0 g/l (Figure 2). 
IAP 12-20 mmHg (group 1 and 2) causes a 
slight increase in the concentration of fibrinogen 
compared to normal values (also lies within normal 
values). 
 
Figure 3: Dependence of the content of D-dimer in plasma on the 
level of IAP 
IAP 21-25 mmHg (group 3) causes an 
increase in fibrinogen concentration compared to 
normal values (there are statistically significant 
differences compared to the control group and group 
1 and 2. 
Statistically significant changes in fibrinogen 
level are observed at IAH 25 mmHg and more (group 
4) in the direction of hypercoagulation, which possibly 
associated with organ dysfunction and consumption 
coagulopathy. 
The average concentration of D-dimer in the 
control group is 5.8 ng/ml. 
IAP 12-15 mmHg (group 1) causes a 
significant increase in the concentration of D-dimer 
compared with the control group in the direction of 
hypercoagulation 4 times compared with normal 
values (Figure 3). 
IAP 16-25 and above mmHg (group 2, 3 and 
4) causes a pronounced statistically significant 
increase in the concentration of D-dimer in the 
direction of hypercoagulation by 5-6 times compared 
to normal values, which confirms the experimental 
data; thus, the determination of the d-dimer level is 
relevant in the development of IAH, since even with 
IAP 12-15 mmHg, there is a clear statistically 
significant dynamics to increase this indicator. 
 
Figure 4: Dependence of the content of sCD14 in plasma on the 
level of IAP 
 
The average concentration of the sCD14 
biomarker of the control group is 246 ng/ml (Figure 4). 
IAH 12-15 mmHg (group 1) causes 
statistically significant changes in the concentration of 
sCD14 compared with the control group. 
IAH 16-25 mmHg (group 2 and 3) causes an 
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increase of the concentration of the biomarker sCD14 
compared with normal values by 30% (there are 
statistically significant differences compared with the 
control group and group 1), which confirms the 
previously conducted experimental studies on the 
beginning of the enterogenous translocation of the 
bacterial flora into the bloodstream IAP level; 
With IAH 25 or more mm Hg (group 4) there is 
acute increasing of the concentration of sCD14 almost 
4 times, which probably indicates the development of 
a “preseptic” state. 
In conclusion, the literature data and our 
results are allowed us to formulate a working 
hypothesis about the change in the level of presepsin, 
fibrinogen, d-dimer, which increase sharply in 
response to an increase in IAP, which leads, 
respectively, to hypercoagulation with further organ 
dysfunction, consumption coagulopathy. 
Having estimated the level of presepsin with 
the development of intraabdominal hypertension, 
there is a clear positive correlation with the high 
sensitivity, specificity (a high level of statistical 
significance p < 0.01 is determined). 
Thus, it can be proposed to use the 
determination of presepsin level in patients with acute 
surgical pathology of the abdominal cavity as a routine 
method along with the determination of fibrinogen, PTI, 
D-dimer to assess the stratification of the risk of 
abdominal sepsis, prognosis of the course and 
outcome of the disease, as well as timely surgical 
treatment. 
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